期刊文献+

1470nm半导体激光经尿道前列腺汽化术治疗BPH的疗效观察 被引量:17

Transurethral vaporization of the prostate using 1470nm diode laser for treatment of BPH
原文传递
导出
摘要 目的:探讨1 470nm半导体激光经尿道前列腺汽化术治疗BPH的疗效和安全性。方法:应用1470nm半导体激光对46例BPH患者进行激光汽化切除术。患者年龄62~86岁,平均前列腺体积为(56.2±12.1)ml。同时观察记录手术时间、术中出血量、手术并发症及手术前后IPSS、生活质量评分(QOL)、最大尿流率(Qmax)及剩余尿量(PVR)等指标,评估其差异有无统计学意义。结果:本组手术全部成功,手术时间平均(75.6±14.8)min,术中无明显出血,无输血病例。术后导尿管留置时间2~4d,平均留置尿管时间(2.5±0.4)d;IPSS术后1个月为(8.8±2.2)分,3个月为(7.6±1.2)分,明显低于术前[(18.5±3.6)分,P〈0.01],Qmax及PVR明显好于术前(P〈0.01)。所有患者均未出现尿失禁及明显的膀胱刺激症状。结论:1 470nm半导体激光汽化术治疗BPH效果肯定,值得临床推广。 Objective: To explore the efficacy and safety of transurethral vaporization of the prostate using 1 470 nm diode laser for treatment of BPH. Method:In our study, we treated 46 BPH patients by 1 470 nm diode laser vaporization. The patients were aged 62-86 years, with a mean prostate volume of (56.2±12.1) ml. We analyzed and compared the data of mean operation time, intra-operative blood loss, postoperative complications, IPSS, quality of life (QOL) score, Q and post-void residual (PVR) before and after surgery. Result:Opera- tions were successful in all the 46 cases, with an average operation time of (75.6 ± 14.8) min, very little blood loss and no blood transfusion. The transurethral catheter indwelling time was 2-4 (mean, 2.5±0.4) days. The patients were followed up for 1-3 months, which revealed a significant reduction in IPPS (P〈0.01) and improve ment in Qmax and PVR (P〈0.01) compared with preoperation. No severe complications were reported, including urinary incontinence and bladder irritation symptoms. None of the patients complained of impaired erectile function. Conclusion: Transurethral vaporization of the prostate using 1 470 nm diode laser is a safe and effective treat ment for BPH.
出处 《临床泌尿外科杂志》 2014年第9期794-796,799,共4页 Journal of Clinical Urology
关键词 良性前列腺增生 半导体激光 经尿道前列腺汽化术 benign prostatic hyperplasia diode laser transurethral vaporization of the prostate
  • 相关文献

参考文献13

  • 1Madersbacher S,Alivizatos G,Nordling J,et al.EAU2004guidelines on assessment,therapy and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction(BPH guidelines)[J].Eur Urol,2004,46:547-554.
  • 2Kaplan S A.AUA guidelines and their impact on the management of BPH:an update[J].Rev Urol,2004,6 (Suppl 9):S46-52.
  • 3Reich O,Seitz M,Gratzke C,et al.Benign prostatic syndrome(BPS).Ablative treatments[J].Urologe A,2006,45:769-780,quiz 781-782.
  • 4Fayad A S,Sheik H M G,Zakaria T,et al.Holmium laser enucleation versus bipolar resection of the prostate:aprospective randomized study.Which to choose[J]?J Endourol,2011,25(8):1347-1352.
  • 5Bouvhier-Hayes D M,Van Appledorn S,Bugeja P,et al.Arandomized trial of photoselective vaporization of the prostate using the 80 W potassium-titanyl-phosphate laser vs transurethral prostatectomy,with a year follow-up[J].BJU Int,2010,105(7):964-969.
  • 6Fu W J,Hong B F,Yang Y,et al.Vaporesection for managing benign prostatic hyperplasia using a 2-micron continuous wave laser:aprospective trial with 1-year follow-up[J].BJU Int,2009,103(3):352-356.
  • 7Michael S,Ronald S,Christian G,et al.The diode laser:a novelside-firing approach for laser vaporisation of the human prostate-immediate efficacy and 1-year follow-up[J].Eur Urol,2007,52(6):1717-1722.
  • 8Seitz M,Ruszat R,Bayer T,Ex vivo and vivo investigation of the novel 1 470nm diode laser for potential treatment of benign prostatic enlargement[J].Lasers Med Sci,2009,24(3):419-424.
  • 9Muir G,Gomez-Sancha F,Bachmann A,et al.Techniquea and training with Grennlight HPS 120 Wlaser therapy of the prostate:Posining paperIbrahiem el-H[J].Eur Urol,2008,7(4):370-375.
  • 10Peterson M D,Matlaga B R,Kim S C,et al.Holmium laser enucleation of the prostate for men with urinary retention[J].J Urol,2005,174(3):998-1001.

同被引文献132

  • 1李连军,金讯波,赵勇,王慕文,孟慧林.前列腺绿激光汽化术后尿频症状的观察及处理(附122例报道)[J].泌尿外科杂志(电子版),2013,5(2):24-28. 被引量:2
  • 2刘萃龙,周茂军,赵豫波,欧阳昀,关维民,吴意光,徐衍盛.1470nm半导体激光汽化术治疗良性前列腺增生症[J].微创泌尿外科杂志,2014,3(2):112-114. 被引量:18
  • 3FU Wei-jun HONG Bao-fa YANG Yong CAI Wei GAO Jiang-ping WANG Chun-yang WANG Xiao-xiong.Photoselective vaporization of the prostate in the treatment of benign prostatic hyperplasia[J].Chinese Medical Journal,2005(19):1610-1614. 被引量:8
  • 4王建业,宋希双,杜传军,等:良性前列腺增生诊断治疗指南[M]//那彦群,叶章群,孙颖浩,等.中园泌尿外科疾病诊断治疗指南.2014版.北京:人民卫生出版社,2013,1(5):245.266.
  • 5那彦群,叶章群,孙颖浩,等.中国泌尿外科疾病诊断治疗指南2014版[M].北京:人民卫生出版社,2014:137..
  • 6Yu X,Elliott SP,Wilt TJ,et al.Practice patterns in benign prostatic hyperplasia surgical therapy:the dramatic increase in minimally invasive technologies[J].J Urol 2008,180(1):241-245.
  • 7Bach T,Musehter R,Sroka R,et al.Laser treatment of benign prostatic obstruction:basics and physical differences[J].Eur Urol,2012,61(2):317-325.
  • 8Seitz M,Ruszat R,Bayer T,et al.Ex vivo and in vivo investigations of the novel 1 470 nm diode laser for potential treatment of benign prostatic enlargement[J].Lasers Med Sci,2009,24(3):419-424.
  • 9Seitz M,Sroka R,Gratzke C,et al.The Diode Laser:A Novel Side-Firing Approach for Laser Vaporisation of the Human Prostate-Immediate Efficacy and 1-Year Follow-Up[J].Eur Urol,2007,52(6):1717-1722.
  • 10Zhao Y,Liu C,Zhou G,et al.A retrospective evaluation of benign prostatic hyperplasia treat-ment by transurethral vaporization using 1470nm laser[J].Photomed Laser Surg,2013,31(12):626-629.

引证文献17

二级引证文献149

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部